Gheorghe Doros, PhD
Boston University School of Public Health
Dept of Biostatistics

PhD, Yale University
MA, Yale University
MS, University of Bucharest

Gheorghe Doros is Professor of Biostatistics and director of the Biostatistics Consulting Group. He received his PhD in Statistics from Yale University and joined BUSPH’s Department of Biostatistics in 2006 after spending two years at Eli Lilly, as a member of that company's Drug Discovery and Toxicology department. Dr. Doros’s research on methodological approaches and strategies has been concentrated in the area of clinical trials, more specifically on Bayesian approaches to clinical trials and the area of placebo response in clinical trials. The outcome of his work has been a corner stone in developing a host of collaborations with outstanding faculty, clinicians, and researchers at the Boston University Medical Campus and at other institutions. These productive collaborations have resulted in several federally funded grants. Dr. Doros authored and co-authored many peer-reviewed publications of original and innovative research which has had a major impact on the field. On the majority of publications, Dr. Doros is the lead statistician author. He demonstrated continuing record of multidisciplinary research that has had a major impact on the rapidly changing field. His publications on clinical trials; most proposing the design, analysis and new methodologies or of significant contributions to this field.

Dr. Doros is a very active and effective teacher and mentor in the department of Biostatistics. His teaching philosophy is to pursue an active approach to learning and to engage students to think critically. He taught core and elective courses for Master and PhD-level courses. The excellent course evaluations he received attests to his ability in engaging students in active learning. Dr. Doros has been awarded the excellence in teaching three times in three years.

On a national level, Dr. Doros has served as an Associate Editor for the BioMed Central’s journal Trials and as a reviewer for a number of academic journals. He served as a member of the merit review subcommittee for Epidemiology of the Department of Veteran Affairs and a member NHLBI-Ancillary Studies in Clinical Trials between 2012 and 2014. He has served as a statistical expert on a number of Independent Data Monitoring Committee(IDMC) for clinical trials and clinical programs. He served or seves as a senior consultant on multicenter trials and/or programs for the following organizations Pfizer, Takeda, Avanir, Sarepta and Children's Hospital.

Boston University
BU-BMC Cancer Center

Boston Medical Center

2008-2010 Boston University School of Public Health: Excellence in Teaching Award

VA241-16-D-0012 VA Master Contract Task Order 24
09/01/2020 - 08/31/2021 (PI)
VA Boston Healthcare System

VA241-16-D-0012 VA Master Contract Task Order 19
05/01/2020 - 08/31/2021 (PI)
VA Boston Healthcare System

Gheorghe Doros, PhD: Statistical research in clinical trials (Baim Institute for Clinical Research)
09/01/2017 - 08/31/2021 (PI)
Baim Institute for Clinical Research

VA241-16-D-0012 VA Master Contract Task Order 18
09/01/2019 - 08/31/2020 (PI)
VA Boston Healthcare System

Personnel Agreement for Research Services of Gheorghe Doros
05/01/2016 - 08/31/2019 (PI)
VA Boston Healthcare System

Gheorghe Doros, PhD (faculty): Statistical research in clinical trials (Harvard Clinical Research Institute)
09/01/2016 - 08/31/2017 (PI)
Harvard Clinical Research Institute

Personnel Agreement for Research Services of Gheorghe Doros
06/01/2012 - 02/28/2016 (PI)
VA Boston Healthcare System

Personnel Agreement for Research Services of Gheorghe Doros
07/01/2012 - 05/31/2013 (PI)
VA Boston Healthcare System

Personnel Agreement for Research Services of Gheorghe Doros
08/01/2009 - 03/31/2012 (PI)
VA Boston Healthcare System

Personnel Agreement for Research Services of Gheorghe Doros
06/01/2008 - 03/31/2012 (PI)
VA Boston Healthcare System

Showing 10 of 11 results. Show All Results


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Nader R, Zhen A, Angel-Korman A, Pavlovich SS, Pogrebinsky A, Doros G, Menn-Josephy H, Stern L, Sanchorawala V, Havasi A. Predictors and outcomes of acute kidney injury during autologous stem cell transplantation in AL amyloidosis. Nephrol Dial Transplant. 2021 May 27.View Related Profiles. PMID: 34043009
  2. Rogers T, Medranda GA, Doros G, Weintraub WS, Waksman R. TAV-in-TAV Versus TAV-in-SAV: A Troublesome Analysis and the Wrong Question. J Am Coll Cardiol. 2021 May 18; 77(19):2450-2451. PMID: 33985690
  3. Garcia MA, Rampon GL, Doros G, Jia S, Jagan N, Gillmeyer K, Berical A, Hudspeth J, Ieong M, Modzelewski KL, Schechter-Perkins EM, Ross CS, Rucci JM, Simpson S, Walkey AJ, Bosch NA. Rationale and Design of the Awake Prone Position for Early Hypoxemia in COVID-19 (APPEX-19) Study Protocol. Ann Am Thorac Soc. 2021 Mar 01.View Related Profiles. PMID: 33647225
  4. Acevedo J, Doros G, Szalat R, Sanchorawala V. Clinical Characteristics, Treatment Regimens, and Survival in Elderly Patients with AL Amyloidosis. Clin Lymphoma Myeloma Leuk. 2021 Feb 02.View Related Profiles. PMID: 33622658
  5. Litz BT, Rusowicz-Orazem L, Doros G, Grunthal B, Gray M, Nash W, Lang AJ. Adaptive disclosure, a combat-specific PTSD treatment, versus cognitive-processing therapy, in deployed marines and sailors: A randomized controlled non-inferiority trial. Psychiatry Res. 2021 Mar; 297:113761.View Related Profiles. PMID: 33540206
  6. Moschovis PP, Sampayo EM, Cook A, Doros G, Parry BA, Lombay J, Kinane TB, Taylor K, Keating T, Abeyratne U, Porter P, Carl J. The diagnosis of respiratory disease in children using a phone-based cough and symptom analysis algorithm: The smartphone recordings of cough sounds 2 (SMARTCOUGH-C 2) trial design. Contemp Clin Trials. 2021 02; 101:106278. PMID: 33444779; PMCID: PMC7990113; DOI: 10.1016/j.cct.2021.106278;
  7. Cheng TW, Raulli SJ, Farber A, Levin SR, Kalish JA, Jones DW, Rybin D, Doros G, Siracuse JJ. The Association of the Day of the Week with Outcomes of Infrainguinal Lower Extremity Bypass. Ann Vasc Surg. 2021 May; 73:43-50.View Related Profiles. PMID: 33370572
  8. Staron A, Connors LH, Zheng L, Doros G, Sanchorawala V. Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities. Blood Cancer J. 2020 11 10; 10(11):118.View Related Profiles. PMID: 33173025; PMCID: PMC7655813; DOI: 10.1038/s41408-020-00385-0;
  9. Haider KS, Haider A, Saad F, Doros G, Hanefeld M, Dhindsa S, Dandona P, Traish A. Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study. Diabetes Obes Metab. 2020 11; 22(11):2055-2068.View Related Profiles. PMID: 32558149; PMCID: PMC7689919; DOI: 10.1111/dom.14122;
  10. Cheng TW, Maithel SK, Kabutey NK, Fujitani RM, Farber A, Levin SR, Patel VI, Jones DW, Rybin D, Doros G, Siracuse JJ. Access Type for Endovascular Repair in Ruptured Abdominal Aortic Aneurysms Does Not Affect Major Morbidity or Mortality. Ann Vasc Surg. 2021 Jan; 70:181-189.View Related Profiles. PMID: 32659419
Showing 10 of 311 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 311 publications over 19 distinct years, with a maximum of 41 publications in 2014

Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map

Doros's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department